# Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma

> **NCT01828736** · PHASE2 · COMPLETED · sponsor: **Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie** · enrollment: 61 (actual)

## Conditions studied

- Recurrent Bladder Cancer
- Stage IV Bladder Cancer
- Transitional Cell Carcinoma of the Bladder

## Interventions

- **BIOLOGICAL:** Trastuzumab
- **DRUG:** Gemcitabine
- **DRUG:** Carboplatin
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01828736
- **Lead sponsor:** Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02-09
- **Primary completion:** 2010-02-23
- **Final completion:** 2010-02-23
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2017-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01828736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01828736, "Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01828736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*